Corient Capital Partners’s Medtronic MDT Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2022
Q3 | $9.15M | Hold |
101,932
| – | – | 0.68% | 30 |
|
2022
Q2 | $9.15M | Sell |
101,932
-5,314
| -5% | -$477K | 0.69% | 32 |
|
2022
Q1 | $11.9M | Buy |
107,246
+579
| +0.5% | +$64.2K | 0.79% | 20 |
|
2021
Q4 | $11M | Buy |
106,667
+8,450
| +9% | +$874K | 0.73% | 22 |
|
2021
Q3 | $12.3M | Buy |
98,217
+11,609
| +13% | +$1.46M | 0.9% | 15 |
|
2021
Q2 | $10.8M | Buy |
86,608
+11,254
| +15% | +$1.4M | 0.79% | 18 |
|
2021
Q1 | $8.9M | Buy |
75,354
+1,553
| +2% | +$183K | 0.76% | 18 |
|
2020
Q4 | $8.65M | Buy |
73,801
+1,274
| +2% | +$149K | 0.86% | 18 |
|
2020
Q3 | $7.54M | Buy |
72,527
+1,316
| +2% | +$137K | 0.87% | 18 |
|
2020
Q2 | $6.53M | Buy |
71,211
+15,996
| +29% | +$1.47M | 0.8% | 26 |
|
2020
Q1 | $4.98M | Sell |
55,215
-3,060
| -5% | -$276K | 0.79% | 28 |
|
2019
Q4 | $6.61M | Buy |
58,275
+1,465
| +3% | +$166K | 0.84% | 20 |
|
2019
Q3 | $6.17M | Buy |
56,810
+1,856
| +3% | +$202K | 0.87% | 18 |
|
2019
Q2 | $5.35M | Buy |
54,954
+476
| +0.9% | +$46.4K | 0.82% | 18 |
|
2019
Q1 | $4.96M | Sell |
54,478
-3,938
| -7% | -$359K | 0.81% | 18 |
|
2018
Q4 | $5.31M | Buy |
58,416
+26,518
| +83% | +$2.41M | 0.95% | 14 |
|
2018
Q3 | $3.14M | Hold |
31,898
| – | – | 0.52% | 47 |
|
2018
Q2 | $2.73M | Buy |
31,898
+9,580
| +43% | +$820K | 0.48% | 64 |
|
2018
Q1 | $1.79M | Buy |
22,318
+3,604
| +19% | +$289K | 0.33% | 88 |
|
2017
Q4 | $1.51M | Buy |
18,714
+1,685
| +10% | +$136K | 0.26% | 97 |
|
2017
Q3 | $1.33M | Sell |
17,029
-5
| -0% | -$389 | 0.25% | 98 |
|
2017
Q2 | $1.51M | Buy |
17,034
+1,120
| +7% | +$99.4K | 0.23% | 110 |
|
2017
Q1 | $1.28M | Buy |
15,914
+3,255
| +26% | +$262K | 0.2% | 119 |
|
2016
Q4 | $902K | Sell |
12,659
-1,860
| -13% | -$133K | 0.16% | 138 |
|
2016
Q3 | $1.25M | Buy |
+14,519
| New | +$1.25M | 0.23% | 110 |
|